CN105504090A - Chondroitin sulfate sodium extracted by combining alkaline hydrolysis-enzyme hydrolysis method and flocculation precipitation method - Google Patents

Chondroitin sulfate sodium extracted by combining alkaline hydrolysis-enzyme hydrolysis method and flocculation precipitation method Download PDF

Info

Publication number
CN105504090A
CN105504090A CN201511000950.5A CN201511000950A CN105504090A CN 105504090 A CN105504090 A CN 105504090A CN 201511000950 A CN201511000950 A CN 201511000950A CN 105504090 A CN105504090 A CN 105504090A
Authority
CN
China
Prior art keywords
chondroitin sulfate
hydrolysis
alkaline hydrolysis
ratio
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201511000950.5A
Other languages
Chinese (zh)
Inventor
刘乃山
夏衬来
迟培升
陆玉梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QINGDAO JIULONG BIO-PHARMACEUTICAL Co Ltd
Original Assignee
QINGDAO JIULONG BIO-PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QINGDAO JIULONG BIO-PHARMACEUTICAL Co Ltd filed Critical QINGDAO JIULONG BIO-PHARMACEUTICAL Co Ltd
Publication of CN105504090A publication Critical patent/CN105504090A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof

Abstract

The invention relates to a chondroitin sulfate sodium extracting method. Chondroitin sulfate sodium is a mucopolysaccharide substance extracted from animal cartilages, such as hog snout cartilages. A traditional process method adopts alkaline hydrolysis, enzyme hydrolysis, slat hydrolysis and ion exchange resin or their combinations to perform extraction, an extracting solution still contains a large amount of protein, nucleic acid and other impurities, and a certain problem is brought to further purification. The chondroitin sulfate sodium extracting method adopts an alkaline hydrolysis-enzyme hydrolysis method and a flocculation precipitation method to remove the impurities left in the chondroitin sulfate extracting solution, is reasonable in process design and high in removing efficiency, the follow-up refine work time is shortened, the product yield is improved, and the method conforms to the standards of Chinese Pharmacopoeia of 2010 edition.

Description

Alkaline hydrolysis-enzymolysis process extracts Sodium chondroitin sulfate A in conjunction with flocculent precipitation
Technical field
Field belonging to the present invention is biochemical pharmacy field, relates to a kind of extracting method of Sodium chondroitin sulfate A, particularly a kind of Sodium chondroitin sulfate A producing and manufacturing technique.
Background technology
Sodium chondroitin sulfate A is a kind of acid mucopolysaccharides extracting preparation from animal cartilaginous tissue, belongs to glycosaminoglycan.Clinically be mainly used in lipid regulating agent, sacroiliitis, eye drop etc.Sodium chondroitin sulfate A is a kind of biochemical drug of outbalance in the market, is recorded in " Chinese Pharmacopoeia (2010 editions) ".In recent years, the trend that Sodium chondroitin sulfate A is consumed as healthcare products heats up gradually, makes its Application Areas more and more extensive.
Traditional process for extracting takes the method for alkaline hydrolysis, enzymolysis, salt solution and ion exchange resin or its combination to extract, extraction efficiency is low, complex operation, still containing the impurity such as a large amount of protein and nucleic acid in extracting solution, brings certain difficult problem to being further purified.
Summary of the invention
Object of the present invention provides a kind of method extracting Sodium chondroitin sulfate A, namely alkaline hydrolysis-enzymolysis process is in conjunction with flocculent precipitation, can effectively remove impurity remaining in extracting solution, effective simplification refining step, save ethanol consumption in settling step, the Sodium chondroitin sulfate A product that foreign matter content is low, yield is good can be produced in the shorter time.
Object of the present invention reaches by the following technical programs, is realized successively by following step.
(1) cartilage soaks: hog snout diaphyseal bone joined with the complete submergence of water in retort, soak after 3-5 hour, puts dry immersion water;
(2) alkaline hydrolysis: add alkali lye, the ratio of dry bone weight and alkali lye weight is 1:2-1:3, stirs and extracts after 3-5 hour, with 100 order nylon net filters;
(3) enzymolysis: after regulating pH8-9, be warming up to 45 DEG C, add pig source pancreatin and sodium-chlor, 45-50 DEG C of insulation 3-5 hour;
(4) rise suddenly temperature: be warming up to 80-85 DEG C, leaves standstill 15-20min, with sock filtration;
(5) ratio of 20%-30% adds 95% ethanol in filtered liquid by volume;
(6) flocculating settling: control temperature 40-50 DEG C, regulates pH11-12, adds flocculating settling agent in 0.3%-0.5% (mass/volume) ratio, and leave standstill until layering, siphon supernatant, the centrifugal rear merging mother liquor of throw out, in supernatant liquor, discards centrifugal slag;
(7) after desolventing technology, alcohol settling, dewatered drying, obtains the Sodium chondroitin sulfate A of separation and purification.
The beneficial effect of the technical program is: through alkaline hydrolysis-enzymolysis process in conjunction with the obtained Sodium chondroitin sulfate A of flocculent precipitation, content more than 90%, yield >=30%.
(1) in the technical program, enzymolysis step adds sodium-chlor in (3), and the weight ratio of its weight and dry bone is 3%-5%.Can hydrolysis result be strengthened, Sodium chondroitin sulfate A is effectively separated with impurity such as albumen.
(2) in the technical program, in alkaline hydrolysis step (2), the concentration of alkali lye used is 1-2mol/L, can reduce the destruction of alkali lye to Sodium chondroitin sulfate A, improves yield.
(3) in the technical program, the pig source pancreatin weight added in enzymolysis step (3) and the weight ratio of dry bone are 1%-2%, and soaking time is 3-5 hour, can reduce the destruction of pancreatin to Sodium chondroitin sulfate A, improve yield.
(4) in the technical program, add ethanol in flocculating settling forward direction filtrate, this alcohol concn is 95%, and is 20%-30% with filtering the volume ratio at night.The combination of the impurity such as protein nucleic acid and flocculating settling agent can be increased like this, increase granularity, contribute to sedimentation.
(5) in the technical program, flocculating settling agent is selected from hydroxyapatite (HAP) and sodium laurylsulfonate (SDBS) or its mixture, can the effective impurity such as associated proteins nucleic acid form throw out, removes after centrifugal.
Embodiment
Following instance describes the present invention in detail:
(1) cartilage soaks: 100Kg hog snout diaphyseal bone joined with the complete submergence of water in retort, soak after 4 hours, puts dry immersion water;
(2) alkaline hydrolysis: add 1mol/L alkali lye 250L, stirs extraction after 4 hours, with 100 order nylon net filters;
(3) enzymolysis: after regulating pH8.5, be warming up to 45 DEG C, add pancreatin 1Kg, add sodium-chlor 3Kg, is incubated 4 hours under 45-50 DEG C of condition;
(4) rise suddenly temperature: be warming up to 80 DEG C, after leaving standstill 20min, with sock filtration;
(5) in filtered liquid, 95% ethanol 80L is added;
(6) flocculating settling: control temperature 45 DEG C, regulate pH=11, add flocculating settling agent 1.2Kg, siphon supernatant after stratification, throw out is centrifugal, merges mother liquor in supernatant liquor, discards centrifugal slag;
(7) after desolventing technology, alcohol settling, dewatered drying, obtains the Sodium chondroitin sulfate A 32.5Kg of separation and purification, and content is 95%, and yield is 32.5%.

Claims (6)

1. alkaline hydrolysis-enzymolysis process extracts Sodium chondroitin sulfate A in conjunction with flocculent precipitation, it is characterized in that:
(1) cartilage soaks: hog snout diaphyseal bone joined with the complete submergence of water in retort, soak after 3-5 hour, puts dry immersion water;
(2) alkaline hydrolysis: add alkali lye, the ratio of dry bone weight and alkali lye weight is 1:2-1:3, stirs and extracts after 3-5 hour, with 100 order nylon net filters;
(3) enzymolysis: after regulating pH8-9, be warming up to 45 DEG C, add pig source pancreatin and sodium-chlor, 45-50 DEG C of insulation 3-5 hour;
(4) rise suddenly temperature: be warming up to 80-85 DEG C, leaves standstill 15-20min, with sock filtration;
(5) ratio of 20%-30% adds 95% ethanol in filtered liquid by volume;
(6) flocculating settling: control temperature 40-50 DEG C, regulates pH11-12, adds flocculating settling agent in 0.3%-0.5% (mass/volume) ratio, and leave standstill until layering, siphon supernatant, the centrifugal rear merging mother liquor of throw out, in supernatant liquor, discards centrifugal slag;
(7) after desolventing technology, alcohol settling, dewatered drying, obtains the Sodium chondroitin sulfate A of separation and purification.
2. in accordance with the method for claim 1, it is characterized by: in alkaline hydrolysis step, the concentration of alkali lye used is 1-2mol/L.
3. in accordance with the method for claim 1, it is characterized by: the weight sodium chloride added in enzymolysis step (3) and the weight ratio of dry bone are 3%-5%; The pig source pancreatin weight added and the weight ratio of dry bone are 1%-2%; Soaking time is 3-5 hour.
4. in accordance with the method for claim 1, it is characterized by: must add ethanol in filtrate before flocculating settling step, this alcohol concn is 95%, and is 20%-30% with filtering the volume ratio at night.
5. in accordance with the method for claim 1, it is characterized by: flocculating settling agent is selected from hydroxyapatite (HAP) and sodium laurylsulfonate (SDBS) or its mixture.
6. in accordance with the method for claim 1, it is characterized by: the Sodium chondroitin sulfate A prepared according to the inventive method meets Chinese Pharmacopoeia (version in 2010) requirement.
CN201511000950.5A 2013-10-21 2013-10-21 Chondroitin sulfate sodium extracted by combining alkaline hydrolysis-enzyme hydrolysis method and flocculation precipitation method Pending CN105504090A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310508887.0A CN103601815B (en) 2013-10-21 2013-10-21 Alkaline hydrolysis-enzymolysis process extracts Sodium chondroitin sulfate A in conjunction with flocculent precipitation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201310508887.0A Division CN103601815B (en) 2013-10-21 2013-10-21 Alkaline hydrolysis-enzymolysis process extracts Sodium chondroitin sulfate A in conjunction with flocculent precipitation

Publications (1)

Publication Number Publication Date
CN105504090A true CN105504090A (en) 2016-04-20

Family

ID=50120089

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201310508887.0A Active CN103601815B (en) 2013-10-21 2013-10-21 Alkaline hydrolysis-enzymolysis process extracts Sodium chondroitin sulfate A in conjunction with flocculent precipitation
CN201511000950.5A Pending CN105504090A (en) 2013-10-21 2013-10-21 Chondroitin sulfate sodium extracted by combining alkaline hydrolysis-enzyme hydrolysis method and flocculation precipitation method

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201310508887.0A Active CN103601815B (en) 2013-10-21 2013-10-21 Alkaline hydrolysis-enzymolysis process extracts Sodium chondroitin sulfate A in conjunction with flocculent precipitation

Country Status (1)

Country Link
CN (2) CN103601815B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111925461A (en) * 2020-08-31 2020-11-13 四川大学 Fibrocartilage glycosaminoglycan and extraction method thereof

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104558245A (en) * 2014-12-24 2015-04-29 青岛九龙生物医药有限公司 Diluted alkali-enzymolysis extraction method for extracting chondroitin sulfate in pig nasal bones
CN105504094B (en) * 2016-01-20 2017-09-29 定陶县地元生化制品有限公司 Liquid and preparation method thereof is digested without sodium ion chondroitin
CN105866109B (en) * 2016-03-28 2018-06-12 北京倍肯恒业科技发展股份有限公司 Phenolphthalein detection method and detection blocking Preparation Method in weight-reducing class health food
CN105866111B (en) * 2016-03-29 2018-05-08 北京倍肯恒业科技发展股份有限公司 Nifedipine detection method and detection blocking Preparation Method in antihypertensive health care food
CN106397629B (en) * 2016-08-30 2019-08-20 集美大学 Method, the chondroitin sulfate by this method extraction and the application of chondroitin sulfate are extracted from sturgeon fish-bone
CN109280094A (en) * 2018-05-18 2019-01-29 山阳县恒桓生物科技有限公司 A kind of method that chondroitin sulfate purification rate is high
CN109384861A (en) * 2018-09-30 2019-02-26 临沂新程金锣肉制品集团有限公司 A kind of method of heparin sodium pulp thickening dermatan sulfate
CN109651529B (en) * 2018-11-14 2020-10-30 宁波绿之健药业有限公司 Preparation method of chondroitin sulfate with high bioavailability

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1884307A (en) * 2006-06-01 2006-12-27 扬州日兴生物化工制品有限公司 Deacetylate chondroitin sulfate preparation technology
CN101851300A (en) * 2010-06-19 2010-10-06 江西海鑫贸易有限公司 Process for extracting chondroitin sulfate
CN102816809A (en) * 2012-07-20 2012-12-12 王世强 Preparing process for calcium chondroitin sulfate
CN103030715A (en) * 2012-12-07 2013-04-10 青岛九龙生物医药有限公司 Method for separating purified heparin sodium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101280027B (en) * 2007-10-18 2011-05-11 山东众山生物科技有限公司 Extracting method of chondroitin sulfate

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1884307A (en) * 2006-06-01 2006-12-27 扬州日兴生物化工制品有限公司 Deacetylate chondroitin sulfate preparation technology
CN101851300A (en) * 2010-06-19 2010-10-06 江西海鑫贸易有限公司 Process for extracting chondroitin sulfate
CN102816809A (en) * 2012-07-20 2012-12-12 王世强 Preparing process for calcium chondroitin sulfate
CN103030715A (en) * 2012-12-07 2013-04-10 青岛九龙生物医药有限公司 Method for separating purified heparin sodium

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
姜涌明等: "《蛋白质化学》", 31 December 1997, 扬州大学农学院 *
焦炳华等: "《中国海洋生化学术会议论文荟萃》", 31 May 2004, 中国生物化学与分子生物学会 海洋生物化学与分子生物学分会 *
郭养浩: "《药物生物技术》", 30 November 2005, 高等教育出版社 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111925461A (en) * 2020-08-31 2020-11-13 四川大学 Fibrocartilage glycosaminoglycan and extraction method thereof
CN111925461B (en) * 2020-08-31 2021-08-31 四川大学 Fibrocartilage glycosaminoglycan and extraction method thereof

Also Published As

Publication number Publication date
CN103601815B (en) 2016-04-13
CN103601815A (en) 2014-02-26

Similar Documents

Publication Publication Date Title
CN103601815B (en) Alkaline hydrolysis-enzymolysis process extracts Sodium chondroitin sulfate A in conjunction with flocculent precipitation
CN100543041C (en) A kind of preparing chondroitin sulfates
CN102295711A (en) Technology for extracting heparin sodium from pig lungs with polypeptide protein powder as combined product
CN103320486B (en) Method for producing chondroitin sulfate with coproduction of hydrolyzed collagen by employing fish cartilage
CN101724677A (en) Method for extracting collagen polypeptide and hydroxyapatite in fish scales by cooking hot extrusion
CN102550900A (en) Method for preparing edible gelatin by means of freshwater fish skin
CN102898541A (en) Method for preparing fish bone chondroitin sulfate
CN104357522A (en) Method for extracting collagen by using ecdysis of giant salamander
CN102732592A (en) Method for preparing freshwater fish bone gelatin by enzyme process
CN108048514B (en) Method for extracting chondroitin sulfate, collagen peptide and protein fat powder from fresh bone
CN102134288B (en) Process for extracting chondroitin sulfate from pigs
CN107188990A (en) The method that chondroitin sulfate is extracted in sturgeon bone
CN104480228A (en) Method for preparing glucosamine by utilizing shrimp and crab shells
CN102887946A (en) Method for extracting sericin from cocoon cooking wastewater by physical method
CN102807511A (en) Method for extracting taurine from mussel
CN103848929A (en) Process for high-efficiently extracting sodium heparin
CN104341539B (en) A kind of enzyme process combines the method that membrane technology one step prepares refined heparin sodium
CN101230369A (en) Extraction method for chondrin
CN104140477A (en) Preparation method for preparing chondroitin sulfate from chicken shanks
CN102827906B (en) Comprehensive extracting process for collagen type II and chondroitin sulfate
CN101961080A (en) Method for removing odor of silkworm pupa protein by utilizing yeast fermentation
CN103804519A (en) Dilute alkaline and enzymolysis extraction process for chondroitin sulfate
CN113402634A (en) Process for improving clarity of chondroitin sulfate
CN102321192A (en) New preparation method of housefly larva chitosan
CN106432405A (en) Silkworm pupa protein refining method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Address after: 266100 Zhuzhou Road, Laoshan District, Shandong, No. 97, No.

Applicant after: Qingdao Jiulong biological medicine group Co., Ltd.

Address before: 266100 Zhuzhou Road, Laoshan District, Shandong, No. 97, No.

Applicant before: Qingdao Jiulong Bio-Pharmaceutical Co., Ltd.

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160420